Dosiomics and Radiomics Guided Precision Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Carcinoma Patients

被引：0
|
作者：
Cui, Y. [1 ]
机构：
[1] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2024年 / 120卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2250
引用
收藏
页码：E112 / E113
页数：2
相关论文
共 50 条
  • [21] Neoadjuvant vs definitive concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma patients
    Chen, Chih-Yi
    Li, Chia-Chin
    Chien, Chun-Ru
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2018, 16
  • [22] Nomogram for predicting pathologic complete response to neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma
    Liu, Guihong
    Chen, Tao
    Zhang, Xin
    Hu, Binbin
    Yu, Jiayun
    CANCER MEDICINE, 2024, 13 (05):
  • [23] Prognostic Significance of Lymphovascular Invasion in Patients with Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy
    Wei-Hsun Chen
    Yen-Lin Huang
    Yin-Kai Chao
    Chi-Ju Yeh
    Hsien-Kun Chang
    Chen-Kan Tseng
    Yun-Hen Liu
    Annals of Surgical Oncology, 2015, 22 : 338 - 343
  • [24] Surgery is crucial for advanced esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy
    Chen, Haiquan
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2018, 155 (06): : 2722 - 2723
  • [25] Genomic characteristics in neoadjuvant chemoradiotherapy for locally advanced esophageal squamous cell carcinoma
    He, Wenwu
    Leng, Xuefeng
    Wang, Kangning
    Mao, Tiaoqin
    Peng, Lin
    Fang, Qiang
    Xiao, Wenguang
    Han, Yongtao
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2020, 11 (06) : 1105 - 1112
  • [26] Predictors of pathological complete response to neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma
    Ren-Wen Huang
    Yin-Kai Chao
    Yu-Wen Wen
    Hsien-Kun Chang
    Chen-Kan Tseng
    Sheng-Chieh Chan
    Yun-Hen Liu
    World Journal of Surgical Oncology, 12
  • [27] Predictors of pathological complete response to neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma
    Huang, Ren-Wen
    Chao, Yin-Kai
    Wen, Yu-Wen
    Chang, Hsien-Kun
    Tseng, Chen-Kan
    Chan, Sheng-Chieh
    Liu, Yun-Hen
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2014, 12
  • [28] Residual tumor characteristics of esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy
    Tang, Han
    Jiang, Dongxian
    Zhang, Shumin
    Zeng, Zhaochong
    Tan, Lijie
    Hou, Yingyong
    Wang, Qun
    Wang, Hao
    Zhu, Jiangyi
    Shen, Yaxing
    Yin, Jun
    Ge, Di
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2021, 162 (06): : 1632 - 1641
  • [29] Esophageal squamous cell carcinoma treated by definitive or neoadjuvant chemoradiotherapy with or without paclitaxel
    Hsu, F. M.
    Cheng, J. C.
    Lin, C. C.
    Lee, Y. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S278 - S278
  • [30] Radiomics Signature Facilitates Organ-Saving Strategy in Patients With Esophageal Squamous Cell Cancer Receiving Neoadjuvant Chemoradiotherapy
    Li, Yue
    Liu, Jun
    Li, Hong-xuan
    Cai, Xu-wei
    Li, Zhi-gang
    Ye, Xiao-dan
    Teng, Hao-hua
    Fu, Xiao-long
    Yu, Wen
    FRONTIERS IN ONCOLOGY, 2021, 10
12345